Ruili Huang Selected Research

Cytochrome P-450 CYP2B6 (CYP2B6)

1/2022

Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruili Huang Research Topics

Disease

19	Neoplasms (Cancer) 12/2021 - 04/2005
11	Infections 12/2020 - 05/2010
7	COVID-19 01/2022 - 01/2020
5	Hypoxia (Hypoxemia) 01/2018 - 09/2009
4	Inflammation (Inflammations) 01/2022 - 09/2009
4	Zika Virus Infection 01/2021 - 10/2016
4	Malaria 12/2015 - 10/2009
3	Cardiotoxicity 01/2022 - 01/2017
3	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 03/2019
3	Neuroblastoma 01/2021 - 05/2017
2	Pain (Aches) 04/2023 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 08/2009
2	Virus Diseases (Viral Diseases) 01/2021 - 07/2015
2	Viremia 12/2020 - 08/2017
2	Flavivirus Infections 12/2020 - 01/2018
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 08/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 04/2012
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2016 - 08/2011
2	Chordoma 07/2013 - 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Carcinogenesis 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Stroke (Strokes) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Atherosclerosis 01/2020
1	Myocardial Infarction 01/2020
1	Rhabdomyolysis 01/2019
1	Rare Diseases (Rare Disease) 02/2018
1	Obesity 01/2018
1	Microcephaly 10/2016

Drug/Important Bio-Agent (IBA)

4	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2005
3	Ether (Diethyl Ether)IBA 01/2022 - 11/2009
3	NF-kappa B (NF-kB)IBA 01/2022 - 05/2010
3	Investigational DrugsIBA 10/2021 - 07/2013
3	CytokinesIBA 01/2020 - 09/2009
2	Antimalarials (Antimalarial Agents)IBA 01/2022 - 10/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 03/2011
2	Niclosamide FDA Link 01/2021 - 02/2016
2	EnzymesIBA 01/2018 - 04/2005
2	Caspase 3 (Caspase-3)IBA 10/2016 - 05/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 11/2009
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2013
2	baicaleinIBA 01/2016 - 04/2012
2	Oxygen (Dioxygen)IBA 12/2009 - 11/2009
2	LigandsIBA 05/2005 - 04/2005
1	Opioid Analgesics (Opioids)IBA 04/2023
1	Auranofin (Ridaura)FDA Link 01/2023
1	AcetylcholinesteraseIBA 01/2023
1	ButyrylcholinesteraseIBA 01/2023
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	baricitinibIBA 01/2022
1	remdesivirIBA 01/2022
1	molnupiravirIBA 01/2022
1	sotrovimabIBA 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	PlatinumIBA 12/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Methylene Blue (Methylthioninium Chloride)FDA Link 12/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	SmokeIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	entinostat (MS 275)IBA 03/2019
1	Histone Deacetylase InhibitorsIBA 03/2019
1	Drug CombinationsIBA 03/2019
1	mocetinostatIBA 03/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	InterferonsIBA 10/2018
1	Food Additives (Food Additive)IBA 01/2018
1	EmetineIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	cephaelinIBA 01/2018
1	Erythrosine (Erythrosin)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	temoporfinIBA 08/2017
1	Amplex RedIBA 05/2017
1	PotassiumIBA 01/2017
1	trametinibIBA 02/2016
1	LuciferasesIBA 02/2016

Therapy/Procedure

20	Therapeutics 01/2023 - 09/2006
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
1	Precision Medicine 02/2018